Methods for the treatment of cellular proliferative disorders
CA 2422245 A1 · Owner: Coffey, Matthew C. · Inventors: Coffey, Matthew C.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention relates to methods of identifying the susceptibility of cells to, reovirus infection by measuring constitutive MAP kinase pathway signaling. The invention also, pertains to methods using reovirus for the treatment of cellular proliferative disorders, and, particularly cellular proliferative disorders wherein the proliferating cells exhibit constitutive, MEK phosphorylation in mammals. In particular, the methods provide for reovirus treatment of, mammals to treat proliferative disorders including breast tumors, a subset of , tumors in which mutation of the Ras gene is not believed to play a significant role.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed March 14, 2003. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended March 14, 2023.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by March 14, 2025.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.